T. SHAW3, L.; HARIPRASAD, I.; V. MESSNER, L.; A. BANSAL, C.; A. SCHECHET, S.; PÉREZ, J. Topical Nepafenac 0.1% or 0.3% for the Treatment of Central Serous Chorioretinopathy: A Case Series of Chronic and Recurrent Disease and Review of the Literature. BOHR International Journal of Current Research in Optometry and Ophthalmology, [S. l.], v. 1, n. 1, p. 74–79, 2022. DOI: 10.54646/bijcroo.2022.19. Disponível em: https://journals.bohrpub.com/index.php/bijcroo/article/view/108. Acesso em: 19 may. 2024.